Kennedy Ryan David, Spafford Marlee M, Douglas Ornell, Brûlé Julie, Hammond David, Fong Geoffrey T, Thompson Mary E, Schultz Annette S H
*PhD †OD, PhD ‡MPH §OD, MSc ∥RN, PhD Johns Hopkins Bloomberg School of Public Health, Institute for Global Tobacco Control, Department of Health, Behavior, and Society, Baltimore, Maryland (RDK); Propel Centre for Population Health Impact (RDK, OD), University of Waterloo Schools of Optometry and Vision Science (MMS) and Public Health and Health Systems (DH), Department of Psychology (GTF), Department of Statistics and Actuarial Science (MET), University of Waterloo, Waterloo, Ontario, Canada; École d'optométrie, Université de Montréal, Montréal, Quebec, Canada (JB); School of Public Health and Health Systems, Waterloo, Ontario, Canada (DH); Ontario Institute for Cancer Research, Toronto, Ontario, Canada (GTF); and Faculty of Nursing, University of Manitoba, Winnipeg, Manitoba, Canada (ASHS).
Optom Vis Sci. 2014 Jul;91(7):769-77. doi: 10.1097/OPX.0000000000000303.
A national census survey of optometrists in Canada measured knowledge of ocular diseases associated with smoking cigarettes and current practice behaviors related to addressing tobacco use with patients, including prevention and cessation. Optometrists were also asked to identify tools to assist addressing tobacco use with patients.
An online bilingual (English/French) survey was developed and an e-mail with a link to the survey was sent to all 4528 optometrists registered in Canada. No participation incentives were provided. Frequency data were tabulated for survey items. Logistic regression models were fit to understand respondent characteristics associated with discussing tobacco use prevention and cessation with patients.
The response rate was 19% (850 responses). Almost all respondents (98%) believed that smoking cigarettes was a risk factor for developing age-related macular degeneration; approximately half (55%) assessed the smoking status of patients during their initial visit; 7% reported that they discussed the benefits of tobacco use prevention with patients younger than 19 years; and 33% reported that they always or regularly assess their patients' interest in quitting smoking. Respondents who completed the survey in English were more likely (odds ratio, 2.4; 95% confidence interval, 1.01 to 5.65) to deliver prevention messaging, compared with respondents who completed the survey in French. Male respondents were less likely to assess patients' interest in quitting (odds ratio, 0.7; 95% confidence interval, 0.50 to 0.97) than female respondents. Most respondents (90%) were interested in a continuing education program about the impact of smoking on vision and eye health as well as strategies for discussing tobacco cessation and prevention.
Optometrists are aware of the impact of smoking on ocular health; however, most respondents do not systematically engage in tobacco use prevention and cessation practices. Providing optometrists with tools, including continuing education, may help support patient conversations about the risks of tobacco use and improve public health.
一项针对加拿大验光师的全国性普查,测量了与吸烟相关的眼部疾病知识以及当前与患者讨论烟草使用(包括预防和戒烟)的实践行为。验光师还被要求确定有助于与患者讨论烟草使用的工具。
开展了一项在线双语(英语/法语)调查,并向加拿大注册的所有4528名验光师发送了带有调查链接的电子邮件。未提供参与激励措施。对调查项目的频率数据进行了制表。采用逻辑回归模型来了解与与患者讨论烟草使用预防和戒烟相关的受访者特征。
回复率为19%(850份回复)。几乎所有受访者(98%)认为吸烟是患年龄相关性黄斑变性的危险因素;约一半(55%)在患者初诊时评估其吸烟状况;7%报告称他们与19岁以下患者讨论过预防烟草使用的益处;33%报告称他们总是或定期评估患者戒烟的意愿。与用法语完成调查的受访者相比,用英语完成调查的受访者更有可能(优势比,2.4;95%置信区间,1.01至5.65)传达预防信息。男性受访者比女性受访者评估患者戒烟意愿的可能性更小(优势比,0.7;95%置信区间,0.50至0.97)。大多数受访者(90%)对关于吸烟对视力和眼部健康的影响以及讨论戒烟和预防策略的继续教育项目感兴趣。
验光师意识到吸烟对眼部健康的影响;然而,大多数受访者并未系统地参与烟草使用预防和戒烟实践。为验光师提供包括继续教育在内的工具,可能有助于支持与患者就烟草使用风险进行的对话,并改善公众健康。